Monthly Archives: August 2014

The major concern with my miracle drug, and others like it, is acquired resistance. Targeted therapies such as crizotinib work beautifully against cancers with the target mutations they are designed to exploit, but not forever. Eventually, the cancer mutates again, … Continue reading →

I just had another beautiful CT scan last week, marking my eleventh month of progression-free survival on crizotinib (Xalkori). The doctor said that results from the study are starting to suggest that people with the ROS1 mutation may actually do … Continue reading →